The extradomain A of fibronectin (EDA) combined with poly(I: C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model

Vaccine

Volumn 30, Issue 15, 2012, Pages 2564-2569

  San Román, Beatriz ^a   De Andrés, Ximena ^a   Muñoz, Pilar María ^a   Obregón, Patricia ^a   Asensio, Aaron C ^a,b   Garrido, Victoria ^a   Mansilla, Cristina ^c   Arribillaga, Laura ^c   Lasarte, Juan José ^c   De Andrés, Damián ^a   Amorena, Beatriz ^a   Grilló, María Jesús ^a  

^a INSTITUTO DE AGROBIOTECNOLOGÍA   (Spain)

^b FideNa   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adjuvants; EDA; HIV; Mice; P24; Vaccine

Indexed keywords

EXTRADOMAIN A OF FIBRONECTIN P24 FUSION PROTEIN; GAG PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; POLYINOSINIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, VIRAL; FEMALE; FIBRONECTINS; GENE PRODUCTS, GAG; HIV CORE PROTEIN P24; IMMUNITY, CELLULAR; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, INBRED BALB C; POLY I-C; RECOMBINANT FUSION PROTEINS;

EID: 84858280033     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.081     Document Type: Article

References (32)

1. Igarashi T., Brown C., Azadegan A., Haigwood N., Dimitrov D., Martin M.A., et al. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med 1999, 5(February (2)):211-216.
2. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279(March (5359)):2103-2106.
3. Mills K.H., Kitchin P.A., Mahon B.P., Barnard A.L., Adams S.E., Kingsman S.M., et al. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. J Immunol 1990, 144(March (5)):1677-1683.
4. Dyer W.B., Kuipers H., Coolen M.W., Geczy A.F., Forrester J., Workman C., et al. Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets. AIDS Res Hum Retrovir 2002, 18(September (14)):999-1010.
5. Schupbach J., Haller O., Vogt M., Luthy R., Joller H., Oelz O., et al. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med 1985, 312(January (5)):265-270.
6. Sesardic D., Dobbelaer R. European union regulatory developments for new vaccine adjuvants and delivery systems. Vaccine 2004, 22(June (19)):2452-2456.
7. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998, 32(July (3)):155-172.
8. Blander J.M., Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006, 440(April (7085)):808-812.
9. George J., Wang S.S., Sevcsik A.M., Sanicola M., Cate R.L., Koteliansky V.E., et al. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform. Am J Pathol 2000, 156(January (1)):115-124.
10. Barilla M.L., Carsons S.E. Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum 2000, 29(February (4)):252-265.
11. Lasarte J.J., Casares N., Gorraiz M., Hervas-Stubbs S., Arribillaga L., Mansilla C., et al. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 2007, 178(January (2)):748-756.
12. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001, 276(March (13)):10229-10233.
13. Mansilla C., Gorraiz M., Martinez M., Casares N., Arribillaga L., Rudilla F., et al. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein. J Hepatol 2009, 51(September (3)):520-527.
14. Mansilla C., Berraondo P., Durantez M., Martínez M., Casares N., Arribillaga L., et al. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain A from fibronectin. Int J Cancer 2011.
15. Zhu Q., Egelston C., Vivekanandhan A., Uematsu S., Akira S., Klinman D.M., et al. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci USA 2008, 105(October (42)):16260-16265.
16. Warger T., Osterloh P., Rechtsteiner G., Fassbender M., Heib V., Schmid B., et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 2006, 108(July (2)):544-550.
17. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 2005, 41(1):207-234.
18. Cheynet V., Verrier B., Mallet F. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification. Protein Expr Purif 1993, 4(5):367-372.
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(August (5259)):680-685.
20. King L.E., Morrison M. The visualization of human erythrocyte membrane proteins and glycoproteins in SDS polyacrylamide gels employing a single staining procedure. Anal Biochem 1976, 71(March (1)):223-230.
21. Mata M., Yao Z.J., Zubair A., Syres K., Paterson Y. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge. Vaccine 2001, 19(January (11-12)):1435-1445.
22. Girard M.P., Osmanov S., Assossou O.M., Kieny M.P. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. Vaccine 2011, 29(August (37)):6191-6218.
23. Kim T.G., Gruber A., Ruprecht R.M., Langridge W.H. Synthesis and assembly of SIVmac Gag p27 capsid protein cholera toxin B subunit fusion protein in transgenic potato. Mol Biotechnol 2004, 28(September (1)):33-40.
24. Ulrich R., Borisova G.P., Gren E., Berzin I., Pumpen P., Eckert R., et al. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. Arch Virol 1992, 126(1-4):321-328.
25. Suzue K., Young R.A. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 1996, 156(January (2)):873-879.
26. Donayre-Torres A.J., Esquivel-Soto E., Gutierrez-Xicotencatl Mde L., Esquivel-Guadarrama F.R., Gomez-Lim M.A. Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli. Virol J 2009, 6:17.
27. Obregon P., Chargelegue D., Drake P.M., Prada A., Nuttall J., Frigerio L., et al. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol J 2006, 4(March (2)):195-207.
28. Kerkmann M., Lochmann D., Weyermann J., Marschner A., Poeck H., Wagner M., et al. Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles. Oligonucleotides 2006, 16(Winter (4)):313-322.
29. Smithey M.J., Renkema K.R., Rudd B.D., Nikolich-Zugich J. Increased apoptosis, curtailed expansion and incomplete differentiation of CD8+ T cells combine to decrease clearance of L. monocytogenes in old mice. Eur J Immunol 2011, 41(May (5)):1352-1364.
30. Xu S., Han Y., Xu X., Bao Y., Zhang M., Cao X. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation. J Immunol 2010, 185(November (10)):5879-5887.
31. Evans L.A., Thomson-Honnebier G., Steimer K., Paoletti E., Perkus M.E., Hollander H., et al. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. AIDS 1989, 3(May (5)):273-276.
32. Albert J., Abrahamsson B., Nagy K., Aurelius E., Gaines H., Nystrom G., et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990, 4(February (2)):107-112.